ArticleSignal transduction and targeted therapy2026

Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations.

Philipp Hafner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.